Manuel Ramos-Casals Selected Research

Rheumatoid Factor

5/2018	Severe, life-threatening phenotype of primary Sjögren's syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry).
4/2017	Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus-Associated Cryoglobulinemia Treated With Direct-Acting Antivirals.
11/2013	Cryoglobulinemic disease.
8/2012	Monoclonal gammopathy related to Sjögren syndrome: a key marker of disease prognosis and outcomes.
4/2010	Sjögren syndrome or sjögren disease? The histological and immunological bias caused by the 2002 criteria.
4/2009	Prevalence and clinical relevance of autoimmune neutropenia in patients with primary Sjögren's syndrome.
7/2008	Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients.
2/2007	Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.
7/2005	Extrahepatic manifestations in patients with chronic hepatitis C virus infection.
3/2005	Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Manuel Ramos-Casals Research Topics

Disease

22	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 03/2003
21	Infections 01/2022 - 08/2002
20	Vasculitis (Vasculitides) 01/2022 - 03/2004
16	Neoplasms (Cancer) 01/2022 - 08/2003
16	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 04/2006
12	Cryoglobulinemia 01/2022 - 08/2003
10	Sarcoidosis (Schaumann Disease) 11/2021 - 03/2004
6	Peripheral Nervous System Diseases (PNS Diseases) 03/2011 - 03/2004
5	Cytopenia 01/2022 - 03/2003
5	Arthritis (Polyarthritis) 05/2021 - 03/2004
5	Virus Diseases (Viral Diseases) 04/2021 - 08/2006
5	Fatigue 01/2021 - 07/2010
5	B-Cell Lymphoma (Lymphoma, B Cell) 01/2017 - 01/2004
5	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2010 - 04/2006
4	Lymphoma (Lymphomas) 01/2022 - 07/2008
4	COVID-19 01/2022 - 01/2021
4	Thrombocytopenia (Thrombopenia) 01/2022 - 03/2003
4	Anemia 01/2022 - 02/2004
4	Dry Eye Syndromes (Dry Eye Syndrome) 10/2021 - 03/2007
4	Uveitis 01/2021 - 03/2004
4	Lupus Nephritis 01/2016 - 06/2011
4	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 07/2015 - 04/2010
4	Leukopenia 01/2015 - 07/2008
4	Rheumatoid Arthritis 10/2011 - 07/2005
4	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2011 - 07/2007
4	Vascular Skin Diseases 02/2007 - 04/2002
3	Systemic Scleroderma (Systemic Sclerosis) 12/2021 - 02/2007
3	Fever (Fevers) 01/2021 - 12/2006
3	Hypertension (High Blood Pressure) 01/2019 - 09/2003
3	Chronic Hepatitis C 04/2017 - 03/2003
3	Lung Diseases (Lung Disease) 01/2015 - 03/2005
3	Liver Diseases (Liver Disease) 12/2013 - 08/2006
3	Renal Insufficiency (Renal Failure) 03/2012 - 11/2008
2	Autoimmune Hepatitis 12/2021 - 01/2010
2	Inflammation (Inflammations) 01/2021 - 05/2015
2	Lymphopenia (Lymphocytopenia) 01/2021 - 05/2018
2	Lymphadenopathy 01/2021 - 01/2020
2	Pain (Aches) 01/2019 - 09/2014
2	Immunoglobulin G4-Related Disease 06/2016 - 07/2015
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 02/2016 - 11/2008
2	Fibrosis (Cirrhosis) 05/2015 - 03/2003
2	Sjogren's Syndrome (Sjogren Syndrome) 09/2014 - 02/2013
2	Arthralgia (Joint Pain) 02/2013 - 07/2010
2	Disease Progression 01/2013 - 07/2003
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 07/2012 - 11/2008
2	Microscopic Polyangiitis 07/2012 - 04/2006
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2011 - 05/2011
2	Myositis (Idiopathic Inflammatory Myopathies) 11/2008 - 02/2004
2	Thyroiditis 07/2008 - 05/2006
2	Raynaud Disease (Raynaud's Disease) 07/2008 - 03/2004
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2005 - 08/2003

Drug/Important Bio-Agent (IBA)

17	AntibodiesIBA 01/2022 - 04/2002
17	CryoglobulinsIBA 01/2022 - 03/2003
14	Rituximab (Mabthera)FDA Link 01/2016 - 01/2004
13	AutoantibodiesIBA 07/2020 - 08/2002
12	Biological ProductsIBA 11/2021 - 07/2005
12	Rheumatoid FactorIBA 05/2018 - 03/2004
10	GlucocorticoidsIBA 01/2022 - 07/2012
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2011 - 07/2005
8	Antiviral Agents (Antivirals)IBA 01/2022 - 03/2005
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2003
8	Antinuclear AntibodiesIBA 01/2019 - 04/2002
7	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 03/2003
7	Etanercept (Enbrel)FDA Link 02/2015 - 07/2007
6	Infliximab (Remicade)FDA Link 11/2011 - 07/2007
5	Immunosuppressive Agents (Immunosuppressants)IBA 12/2021 - 09/2003
5	Immunoglobulin G (IgG)IBA 04/2017 - 02/2004
4	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 02/2013
4	Immune Checkpoint InhibitorsIBA 11/2021 - 05/2019
4	CytokinesIBA 05/2021 - 08/2002
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 03/2007
4	Immunoglobulins (Immunoglobulin)IBA 11/2013 - 03/2005
4	Pharmaceutical PreparationsIBA 04/2012 - 03/2004
3	Monoclonal AntibodiesIBA 01/2022 - 03/2011
3	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 10/2018 - 02/2004
3	Immunoglobulin M (IgM)IBA 04/2017 - 11/2008
3	DNA (Deoxyribonucleic Acid)IBA 11/2011 - 02/2004
3	Adalimumab (Humira)FDA Link 07/2011 - 07/2007
2	Janus Kinase InhibitorsIBA 01/2022 - 05/2021
2	Oxygen (Dioxygen)IBA 01/2022 - 01/2021
2	Immunologic Factors (Immunomodulators)IBA 01/2022 - 01/2021
2	Antimalarials (Antimalarial Agents)IBA 12/2021 - 11/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 11/2008
2	AutoantigensIBA 04/2021 - 05/2015
2	SteroidsIBA 01/2021 - 09/2015
2	Antigen-Antibody Complex (Immune Complex)IBA 04/2017 - 01/2016
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2016 - 07/2005
2	SS-A antibodiesIBA 09/2015 - 03/2004
2	Immunoglobulin E (IgE)IBA 07/2015 - 06/2011
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 07/2012 - 02/2007
2	Pilocarpine (Ocusert)FDA LinkGeneric 07/2010 - 03/2007
2	cevimeline (Evoxac)FDA Link 07/2010 - 03/2007
2	Complement System Proteins (Complement)IBA 04/2010 - 02/2004

Therapy/Procedure

38	Therapeutics 01/2022 - 03/2003
8	Biological Therapy 12/2016 - 11/2008
5	Immunotherapy 01/2022 - 01/2018
3	Off-Label Use 01/2016 - 11/2008
2	Immunomodulation 01/2022 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2019 - 12/2016
2	Aftercare (After-Treatment) 06/2016 - 03/2005